According to a new report Europe Electrocardiograph (ECG) Market, published by KBV research, the Europe Electrocardiograph (ECG) Market Size would witness market growth of 5.1% CAGR during the forecast period (2017 - 2023).
The Germany market held the largest share in the Europe Electrocardiograph (ECG) Market by Country in 2016, and would continue to be a dominant market till 2023, growing at a CAGR of 3.7 % during the forecast period. The France market is expected to witness a CAGR of 6.5% during (2017 - 2023).
The Resting ECG market held the largest share in the France Electrocardiograph (ECG) Market by Product in 2016, and would continue to be a dominant market till 2023The Electrocardiograph (ECG) Stress ECG market is expected to witness a CAGR of 6.1% during (2017 - 2023).
The 3-6 Lead ECG market held the largest share in the Spain Electrocardiograph (ECG) Market by Lead Type in 2016, and would continue to be a dominant market till 2023, growing at a CAGR of 6.2% during the forecast period.
The Wireless ECG Systems market dominated the in 2016, and would continue to be a dominant market till 2023. The Portable ECG Systems market is expected to witness a CAGR of 6.9% during (2017 - 2023).
Full Report: https://www.kbvresearch.com/europe-electrocardiograph-ecg-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the countries in the region. The key impacting factors of the Europe Electrocardiograph (ECG) Market have been discussed in the report with the elaborated company profiles of Compumed, Bionet, Mindray Medical International Limited, General Electric (GE) (GE Healthcare), Koninklijke Philips N.V (Philips Healthcare), Schiller AG, Welch Allyn, Nihon Kohden Corporation, Medtronic, and Opto Circuits Limited.
By Product
By Lead Type
By End User
By Geography
Companies Profiled
Unique Offerings from KBV Research
Related Reports:
Global Electrocardiograph (ECG) Market
North America Electrocardiograph (ECG) Market